These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18095919)

  • 1. Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market?
    Albers LJ; Musenga A; Raggi MA
    Expert Opin Investig Drugs; 2008 Jan; 17(1):61-75. PubMed ID: 18095919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of iloperidone for the treatment of schizophrenia.
    Jain KK
    Expert Opin Investig Drugs; 2000 Dec; 9(12):2935-43. PubMed ID: 11093363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iloperidone for schizophrenia.
    Rado J; Janicak PG
    Expert Opin Pharmacother; 2010 Aug; 11(12):2087-93. PubMed ID: 20586713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iloperidone for the management of adults with schizophrenia.
    Crabtree BL; Montgomery J
    Clin Ther; 2011 Mar; 33(3):330-45. PubMed ID: 21600386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New atypical antipsychotics for schizophrenia: iloperidone.
    Caccia S; Pasina L; Nobili A
    Drug Des Devel Ther; 2010 Feb; 4():33-48. PubMed ID: 20368905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iloperidone: Does it have a meaningful place in therapy?
    Dopheide JA
    Am J Health Syst Pharm; 2011 Feb; 68(4):297. PubMed ID: 21289322
    [No Abstract]   [Full Text] [Related]  

  • 7. Iloperidone for the treatment of schizophrenia.
    Marino J; Caballero J
    Ann Pharmacother; 2010 May; 44(5):863-70. PubMed ID: 20388862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iloperidone: A new drug for the treatment of schizophrenia.
    Arif SA; Mitchell MM
    Am J Health Syst Pharm; 2011 Feb; 68(4):301-8. PubMed ID: 21289324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iloperidone: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, regulatory affairs, and an opinion.
    Citrome L
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1551-64. PubMed ID: 21034370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iloperidone for the treatment of schizophrenia.
    Bishop JR; Bishop DL
    Drugs Today (Barc); 2010 Aug; 46(8):567-79. PubMed ID: 20830317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders.
    Kalkman HO; Subramanian N; Hoyer D
    Neuropsychopharmacology; 2001 Dec; 25(6):904-14. PubMed ID: 11750183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iloperidone: a new option for the treatment of schizophrenia.
    Cutler AJ
    Expert Rev Neurother; 2009 Dec; 9(12):1727-41. PubMed ID: 19951132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor profile of P88-8991 and P95-12113, metabolites of the novel antipsychotic iloperidone.
    Subramanian N; Kalkman HO
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):553-60. PubMed ID: 11999907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone for chronic schizophrenia.
    Med Lett Drugs Ther; 1994 Apr; 36(920):33-4. PubMed ID: 7511777
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological profile of risperidone.
    Ereshefsky L; Lacombe S
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S80-8. PubMed ID: 7504573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iloperidone for the treatment of schizophrenia: an updated clinical review.
    Weiden PJ
    Clin Schizophr Relat Psychoses; 2012 Apr; 6(1):34-44. PubMed ID: 22453868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults.
    Bobo WV
    Expert Rev Clin Pharmacol; 2013 Jan; 6(1):61-91. PubMed ID: 23272794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2009 Aug; 63(8):1237-48. PubMed ID: 19624791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies.
    Potkin SG; Litman RE; Torres R; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S4-11. PubMed ID: 18334911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety profile of iloperidone in the treatment of schizophrenia.
    Dargani NV; Malhotra AK
    Expert Opin Drug Saf; 2014 Feb; 13(2):241-6. PubMed ID: 24206391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.